Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors. Clin Cancer Res. 2015 May 01; 21(9):2115-26.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Agents
Apoptosis
Apoptosis
Blotting, Western
Blotting, Western
B-Lymphocytes
B-Lymphocytes
Cells, Cultured
Cells, Cultured
Coculture Techniques
Coculture Techniques
Drug Synergism
Drug Synergism
Flow Cytometry
Flow Cytometry
Humans
Humans
Immunoprecipitation
Immunoprecipitation
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphocytic, Chronic, B-Cell
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins
Pyrimidines
Pyrimidines
Receptor Protein-Tyrosine Kinases
Receptor Protein-Tyrosine Kinases
Sulfonamides
Sulfonamides
Transfection
Transfection
authors with profiles
Asish K Ghosh